The Centers for Disease Control and Prevention (CDC) expects updated COVID-19 vaccines from Pfizer, Moderna, and Novavax to be available to the public in mid-September, providing a more specific timeline for the arrival of the shots, pending approvals from the FDA and CDC.
The United States is still weeks away from distributing Covid booster shots, despite a 21.6% increase in hospitalizations related to the virus, and the effectiveness of the boosters against new virus variants remains uncertain.
The U.S. is experiencing a rise in Covid cases just as new vaccines that protect against the latest variants are almost ready.
The FDA has approved updated COVID-19 vaccine and booster shots, targeting new variants, and making them available for Americans as young as 6 months old from Moderna and Pfizer.
Americans can now receive an updated COVID-19 vaccine to reduce the severity of symptoms, protect against current variants, and curb the risk of "long COVID."
Novavax's COVID-19 vaccine has been authorized for adults and children 12 and up, joining Pfizer and Moderna's vaccines, and there are also options available for flu and RSV vaccinations, with the CDC recommending that high-risk individuals get all three vaccines to protect against respiratory viruses.
Vaccine maker Novavax has shipped millions of doses of its updated COVID-19 shots to distributors after receiving clearance from U.S. regulators, with the shots expected to be available at U.S. pharmacies this week.
